The Impact of SARS-CoV-2 on Inflammatory Bowel Disease

GE Port J Gastroenterol. 2020 Jul;27(4):227-229. doi: 10.1159/000508114. Epub 2020 May 5.

Maria Manuela Estevinho^{1

2}, Fernando Magro^{1

3

4

5}

¹ Department of Biomedicine, Unit of Pharmacology and Therapeutics, Faculty of Medicine, University of Porto, Porto, Portugal.
² Department of Gastroenterology, Centro Hospitalar Vila Nova de Gaia/Espinho, Vila Nova de Gaia, Portugal.
³ Department of Gastroenterology, Centro Hospitalar São João, Porto, Portugal.
⁴ MedInUP, Center for Drug Discovery and Innovative Medicines, Porto, Portugal.
⁵ Unidade de Farmacologia Clínica, Centro Hospitalar Universitário de São João, Porto, Portugal.

No abstract available

Keywords: COVID-19; Crohn's disease; SARS-CoV-2; Ulcerative colitis.

Publication types